menu toggle

Company News

Two doctors sitting and looking at an iPad screen together

Industry Spotlights

Q5146 Q-Code for HERCESSITM (trastuzumab-strf)

February 2025

NOW APPROVED in LS-SCLC

February 2025

Take advantage of this deal

February 2025

Zolbetuximab-clzb (VYLOY) Now Recommended in NCCN Guidelines

February 2025

505(b)(2) Pemetrexed for Injection

January 2025

See the only HHI contracted with ION

January 2025

J0870 permanent J-code for RYTELO (imetelstat)

January 2025

BRAFTOVI® (encorafenib) just landed in a new indication as part of a regimen

January 2025

RE: Phase III data on tolerability in mHSPC

January 2025

Now Approved: A treatment for 3L+ FL

December 2024

Now Approved: A treatment for 3L+ FL

December 2024

Save on the only contracted HHI with ION

December 2024

Save on the only contracted HHI with ION

December 2024

Watch an expert perspective about this 1L aRCC therapy

December 2024

Clinical data for your mHSPC and nmCRPC patients

November 2024

Save with the only contracted HHI for laBCC

November 2024

Guideline Recommendations for Certain Patients With nmCSPC

November 2024

Now FDA approved for advanced gastric/GEJ cancer positive for CLDN18.2

November 2024

How do experts evaluate treatment with CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab)?

October 2024

SCEMBLIX® (asciminib) tablets now approved for a new indication

October 2024

Now Approved: A treatment for 3L+ FL

October 2024

Eribulin Mesylate Injection from Long Grove Pharmaceuticals

October 2024

Learn about the only hedgehog pathway inhibitor (HHI) contracted with ION

October 2024

Discover the Benefits of 2-in-1 for your BRCA+ mCRPC Patients

October 2024

Indication for ENHERTU® (fam-trastuzumab deruxtecan-nxki)

October 2024

505(b)(2) Palonosetron Injection

October 2024

Sponsored: Uncover what only ZOLADEX (goserelin implant) can offer

October 2024

Explore safety data from a 6-year follow-up analysis in 1L CLL

October 2024

Data you'll want to see in 3 indications

September 2024

Sponsored Message: Available for earlier lines—CAR-T cell therapy for RRMM

September 2024

505(b)(2) Cyclophosphamide Injection

August 2024

Discover a versatile treatment option in RRMM

August 2024

Discover potential savings with ION

August 2024

Sponsored: ZOLADEX (goserelin implant) information for AON

August 2024

Sponsored: ZOLADEX (goserelin implant) information for Athena Oncology

August 2024

View a TKI combo Rx option and clinical evidence

August 2024

Dosing options for a RRMM treatment

August 2024

Examine real-world evidence insights on prostate-specific antigen (PSA) in patients with metastatic castration-sensitive prostate cancer (mCSPC)

August 2024

Media mentions

Media Mention

Addressing Access and Affordability Issues With Collaboration at Asembia 2024


May 6, 2024

Learn more

Media Mention

Understanding State Regulations and Advocating for Medically Integrated Dispensing


May 3, 2024

Learn more

Media Mention

Biosimilar Legislation Making Moves in the Right Direction


May 2, 2024

Learn more